Evaluation of Color Doppler in Guiding Prostate Biopsy after HIFU Ablation

European Urology

Volumn 50, Issue 3, 2006, Pages 490-497

  Rouvière, Olivier ^a   Mège Lechevallier, Florence ^a   Chapelon, Jean Yves ^b   Gelet, Albert ^a   Bouvier, Raymonde ^a   Boutitie, Florent ^c   Lyonnet, Denis ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b INSERM   (France)

^c Department of Biostatistics ^*  (France)

Author keywords

Color Doppler; HIFU therapy; Prostate biopsy; Prostate neoplasms

Indexed keywords

HORMONE;

AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER RECURRENCE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; EVALUATION; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

AGED; BIOPSY; CARCINOMA; ENDOSCOPY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PROSTATE; PROSTATIC NEOPLASMS; STATISTICS; STATISTICS AS TOPIC; ULTRASONIC THERAPY; ULTRASONOGRAPHY, DOPPLER, COLOR; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 33746917225     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.12.046     Document Type: Article

References (38)

1. Aus G., Abbou C.C., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 48 (2005) 546-551
2. Gelet A., Chapelon J.Y., Bouvier R., Rouvière O., Lyonnet D., and Dubernard J.M. Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome. Eur Urol 40 (2001) 124-129
3. Thuroff S., Chaussy C., Vallencien G., et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol 17 (2003) 673-677
4. Blana A., Walter B., Rogenhofer S., and Wieland W.F. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-Year experience. Urology 63 (2004) 297-300
5. Gelet A., Chapelon J.Y., Poissonnier L., et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 63 (2004) 625-629
6. Gelet A., Chapelon J.Y., Bouvier R., Pangaud C., and Lasne Y. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results. J Urol 161 (1999) 156-162
7. Gelet A., Chapelon J.Y., Bouvier R., et al. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol 29 (1996) 174-183
8. Rouvière O., Lyonnet D., Raudrant A., et al. MRI appearance of prostate following transrectal HIFU ablation of localized cancer. Eur Urol 40 (2001) 265-274
9. Soloway M.S., and Obek C. Periprostatic local anesthesia before ultrasound guided prostate biopsy. J Urol 163 (2000) 172-173
10. Kelly I., Lees W.R., and Rickards D. Prostate cancer and the rôle of color Doppler US. Radiology 189 (1993) 153-156
11. Newman J.S., Bree R.L., and Rubin J.M. Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site. Radiology 195 (1995) 86-90
12. Cornud F., Belin X., Piron D., et al. Color Doppler guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for non palpable lesions. Urology 49 (1997) 709-715
13. Lavoipierre A.M., Snow R.M., Frydenberg M., et al. Prostatic cancer: role of color Doppler imaging in transrectal sonography. AJR Am J Roentgenol 171 (1998) 205-210
14. Shigeno K., Igawa M., Shiina H., Wada H., and Yoneda T. The role of colour Doppler ultrasonography in detecting prostate cancer. Br J Urol 86 (2000) 229-233
15. Halpern E.J., and Strup S.E. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR Am J Roentgenol 174 (2000) 623-627
16. Kuligowska E., Barich M.A., Fenlon H.M., and Blake M. Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers. Radiology 220 (2001) 757-764
17. Kravchick S., Cytron S., Peled R., Altshuler A., and Ben-Dor D. Using gray-scale and two different techniques of color Doppler sonography to detect prostate cancer. Urology 61 (2003) 977-981
18. Roy C., Buy X., Lang H., Saussine C., and Jacqmin D. Contrast enhanced color Doppler endorectal sonography of the prostate: efficiency for detecting peripheral zone tumors and role for biopsy procedure. J Urol 170 (2003) 69-72
19. Sedelaar J.P.M., Vijverberg P.L.M., De Reijke T.M., et al. Transrectal ultrasound in the diagnosis of prostate cancer: state of the art and perspectives. Eur Urol 40 (2001) 275-284
20. Rifkin M.D., Sudakoff G.S., and Alexander A.A. Prostate: techniques, results and potential applications of color Doppler US scanning. Radiology 186 (1993) 509-513
21. Sedelaar J.P.M., Aarnick R.G., Van Leenders G.J.L.H., et al. The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer. Eur Urol 37 (2000) 559-568
22. Susani M., Madersbacher S., Kratzik C., Vingers L., and Marberger M. Morphology of tissue destruction induced by focused ultrasound. Eur Urol 23 (1993) 34-38
23. Halpern E.J., Rosenberg M., and Gomella L.G. Prostate cancer: contrast-enhanced US for detection. Radiology 219 (2001) 219-225
24. Rouvière O., Curiel L., Chapelon J.Y., et al. Can color Doppler predict the uniformity of HIFU-induced prostate tissue destruction? Prostate 60 (2004) 289-297
25. Eckersley R.J., Sedelaar J.P., Blomley M.J., et al. Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma. Prostate 51 (2002) 256-267
26. Padhani A.R., MacVicar A.D., Gapinski C.J., et al. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging. Radiology 218 (2001) 365-374
27. Rubin J.M. Power Doppler. Eur Radiol 9 suppl 3 (1999) 318-322
28. Remzi M., Dobrovits M., Reissigl A., et al. Can power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy?. Eur Urol 46 (2004) 451-456
29. Halpern E.J., McCue P.A., Aksnes A.K., Hagen E.K., Frauscher F., and Gomella L.G. Contrast-enhanced US of the prostate with Sonazoid: comparison with whole-mount prostatectomy specimens in 12 patients. Radiology 222 (2002) 361-366
30. Arger P.H., Malkowicz S.B., Van Arsdalen K.N., Sehgal C.M., Holzer A., and Schultz S.M. Color and power Doppler sonography in the diagnosis of prostate cancer: comparison between vascular density and total vascularity. J Ultrasound Med 23 (2004) 623-630
31. Ragde H., Kenny G.M., Murphy G.P., and Landin K. Transrectal ultrasound microbubble contrast angiography of the prostate. Prostate 32 (1997) 279-283
32. Bogers H.A., Sedelaar JPM, Beerlage H.P., et al. Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 54 (1999) 97-104
33. Halpern E.J., Frauscher F., Rosenberg M., and Gomella L.G. Directed biopsy during contrast-enhanced sonography of the prostate. AJR Am J Roentgenol AJR 178 (2002) 915-919
34. Pepe P., Patane D., Panella P., and Aragona F. Does the adjunct of echographic contrast medium Levovist improve the detection rate of prostate cancer?. Prostate Cancer Prostatic Dis 6 (2003) 159-162
35. El-Gabry E.A., Halpern E.J., Strup S.E., and Gomella L.G. Imaging prostate cancer: current and future applications. Oncology 15 (2001) 1-4
36. Rouvière O., Valette O., Grivolat S., et al. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor-correlation with biopsy findings. Urology 63 (2004) 922-927
37. Parivar F., Hricak H., Shinohara K., et al. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Urology 48 (1996) 594-599
38. Mehta S.S., Azzouzi A.R., and Hamdy F.C. Three dimensional ultrasound and prostate cancer. World J Urol 22 (2004) 339-345